Potassium Acetate
CAS 127-08-2
Potassium Acetate (CAS 127-08-2) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 56 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Gingival disorder | 9 | 29.793 | 10018280 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| POTASSIUM ACETATE | 54987 | SU | MTHSPL |
| potassium acetate | 54987 | SU | MTHSPL |
| potassium acetate | 54987 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Potassium Acetate used for in pharmaceutical contexts?
Potassium Acetate (CAS 127-08-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Potassium Acetate?
Potassium Acetate has 56 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Gingival disorder, Abdominal pain, Abdominal pain upper, Bile duct stone, Blood magnesium decreased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Potassium Acetate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Potassium Acetate with EU status "permitted".
What clinical phase is Potassium Acetate in?
Potassium Acetate is rendered with ChEMBL max phase 4 (approved).